Skip to content
Search

Latest Stories

One in three people in UK miss work due to delays in accessing NHS care: Savanta poll

One in three people in UK miss work due to delays in accessing NHS care: Savanta poll

 Young adults aged 18 to 34 years were worst affected, more than half this working population were forced to miss work as they pursued or waited for NHS care

Long waiting times for National Health Service (NHS) care are leaving people too sick to work in the UK, which is affecting the country’s economy.


One in three people missed work in 2022 due to delays in accessing NHS care, revealed a new survey by Pollsters Savanta.

The market research consultancy surveyed 2,235 people in the UK this month on behalf of the Liberal Democrats.

According to the survey results, 19 per cent of the participants could not go to work as they were waiting for a GP appointment.

While 15 per cent of the respondents had to take a long period off work while they waited for treatment or surgery, 12 per cent missed work as they waited for emergency dental treatments.

Overall, 36 per cent of those surveyed had missed at least some work because of difficulty getting NHS care.

Sarah Olney, a Liberal Democrat Treasury spokesperson, has expressed strong disappointment that so many patients have been left to suffer “as a result of this Conservative government’s neglect.”

“[Rishi] Sunak and [Jeremy] Hunt’s failure to get a grip on the crisis in our NHS is having a detrimental effect on the entire country. Millions battling health conditions have been left in limbo and our economy is suffering as a result,” Olney told The Guardian.

The Savanta poll found that more than half (54 per cent) of young adults aged 18 to 34 years have been forced to miss work while they pursued or waited for care, such as an appointment with a family doctor.

More people out of work because of long-term sickness

Last year, Office for National Statistics (ONS) revealed that around 2.5 million people in the UK were out of the labour force between June and August 2022 because of “long-term sickness.”

The number of working-age adults who were economically inactive because of long-term sickness were around 2.0 million people in spring 2019.

Since the COVID-19 pandemic hit the UK in early 2020, the number of people out of work because of long-term sickness has risen by 363,000, it stated.

Mental health, musculoskeletal conditions and heart disease were some of the main causes of long-term sickness or disability.

According to the ONS, the industries that saw the highest levels of long-term sickness rates were wholesale and retail, transport and storage, accommodation and food service, and health and social sector.

It cited a range of factors behind this recent rise in economic inactivity, including National Health Service (NHS) waiting times, long COVID, and the ageing workforce.

It is estimated that over 9 million people across the UK are waiting for hospital care, mostly in England (almost 7.8 million).

Back to Work Plan  

Chancellor Jeremy Hunt and Secretary of State for Work and Pensions, Mel Stride recently unveiled a “Back to Work Plan” to get more people into work.

It aims to help up to 1,100,000 people with long-term health conditions, disabilities or long-term unemployment to look for and stay in work.

To execute the plan, the government is investing £2.5 billion over the next five years - including over £300m of additional investment next year

It will be built on the £7 billion package announced at this year’s Spring Budget, which included investment targeted at services for mental health, musculoskeletal conditions and cardiovascular disease.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less